Close Menu

North Shore-LIJ

Modulate the Dose

CBS New York reports that pharmacogenomic testing can explain why some patients do not get relief from certain treatments.

The two entities also plan to work together using the data generated from the tests to do added research.

It will be the first comprehensive clinical-oriented collaboration for CSHL, and is expected to enable the institution to more quickly move its basic biomarker and therapeutic discoveries to the clinic.

Cold Spring Harbor Laboratory partners with the North Shore-LIJ Health System to pursue cancer therapeutics research.

Novavax has begun a phase III trial of its SARS-CoV-2 vaccine, according to the New York Times.

Vox reports that the Trump Administration may limit student visas for individuals from some countries to two years.

The governor of New York says the state will conduct its own review of any SARS-CoV-2 vaccine, NPR reports.

This week in Science: Neanderthal Y chromosomes replaced by Homo sapiens Y chromosomes, and more.